| Literature DB >> 25626864 |
Fergal M Grace1, Peter Herbert2, John W Ratcliffe1, Karl J New3, Julien S Baker1, Nicholas F Sculthorpe1.
Abstract
Aging is associated with diffuse impairments in vascular endothelial function and traditional aerobic exercise is known to ameliorate these changes. High intensity interval training (HIIT) is effective at improving vascular function in aging men with existing disease, but its effectiveness remains to be demonstrated in otherwise healthy sedentary aging. However, the frequency of commonly used HIIT protocols may be poorly tolerated in older cohorts. Therefore, the present study investigated the effectiveness of lower frequency HIIT (LfHIIT) on vascular function in a cohort of lifelong sedentary (SED; n = 22, age 62.7 ± 5.2 years) men compared with a positive control group of lifelong exercisers (LEX; n = 17, age 61.1 ± 5.4 years). The study consisted of three assessment phases; enrolment to the study (Phase A), following 6 weeks of conditioning exercise in SED (Phase B) and following 6 weeks of low frequency HIIT in both SED and LEX (LfHIIT; Phase C). Conditioning exercise improved FMD in SED (3.4 ± 1.5% to 4.9 ± 1.1%; P < 0.01) such that the difference between groups on enrolment (3.4 ± 1.5% vs. 5.3 ± 1.4%; P < 0.01) was abrogated. This was maintained but not further improved following LfHIIT in SED whilst FMD remained unaffected by LfHIIT in LEX. In conclusion, LfHIIT is effective at maintaining improvements in vascular function achieved during conditioning exercise in SED. LfHIIT is a well-tolerated and effective exercise mode for reducing cardiovascular risk and maintaining but does not improve vascular function beyond that achieved by conditioning exercise in aging men, irrespective of fitness level.Entities:
Keywords: Aging; angiogenesis; high intensity interval training; vascular function
Year: 2015 PMID: 25626864 PMCID: PMC4387763 DOI: 10.14814/phy2.12234
Source DB: PubMed Journal: Physiol Rep ISSN: 2051-817X
Figure 1.Flow diagram depicting transit of lifelong sedentary (SED) and lifelong exercising (LEX) participants through the study.
Participant characteristics for lifelong sedentary (SED) and lifelong exercising (LEX) aging males that enrolled to and completed the study. Data are presented as means (± SD)
| SED | LEX | |
|---|---|---|
| Number of participants | 22 | 17 |
| Age (years) | 62.7 ± 5.2 | 61.1 ± 5.4 |
| Stature (cm) | 175 ± 6.1 | 173 ± 5.5 |
| Body Mass (kg) | 89.9 ± 17.1 | 79.5 ± 12.3 |
| Body Mass Index (kg m2) | 29.3 ± 5.0 | 26.4 ± 3.0 |
Denotes significant (P <0.01) difference between groups.
Figure 2.Schematic depicting study design incorporating three testing phases (A, B, and C) of two distinct training blocks for lifelong sedentary (SED) and lifelong exercising (LEX) groups.
Figure 3.(A) Graph showing group mean weekly percentage heart rate reserve (%HRR) responses for lifelong sedentary men (SED) during exercise training in Training Block 1. (B) Depicts group mean %HRR for SED and a lifelong exercisers (LEX) during each of nine high intensity interval training (HIIT) sessions. Data are presented as mean ± SD. (C) Depicts group mean power output (MPO) for SED LEX during each of nine HIIT sessions. Data are presented as mean ± SD.
Figure 4.Changes in flow mediated dilatation (FMD: (A) and :(B) in lifelong sedentary (SED) and lifelong exercisers (LEX) on enrolment to the study (Phase A); following conditioning exercise (Phase B) and following low frequency high intensity exercise (LHIIT; Phase C). Data are presented as mean ± SD. **P <0.01 versus LEX and same time‐point, aP <0.01 versus Phase A in the same group, bP <0.01 versus Phase B in the same group.
Determinants of vascular function and biomarkers of angiogenesis for lifelong sedentary and lifelong exercisers on enrolment to the study (Phase A); following conditioning exercise (Phase B) and following low frequency high intensity exercise (LHIIT; Phase C). Data are presented as mean ± SD
| SED | LEX | |||||
|---|---|---|---|---|---|---|
| Phase A | Phase B | Phase C | Phase A | Phase B | Phase C | |
| Brachial Diameter (mm) | 4.9 ± 0.05 | 4.8 ± 0.05 | 5.0 ± 0.06 | 5.1 ± 0.05 | 5.0 ± 0.06 | 5.0 ± 0.06 |
| SRAUC ( | 15.1 ± 4.0 | 14.7 ± 3.6 | 16.4 ± 4.3 | 15.5 ± 3.0 | 16.5 ± 2.9 | 16.0 ± 4.3 |
| IGF‐I (ng mL−1) | 13 ± 4.6 | 15 ± 5.8 | 17 ± 4.5 | 18 ± 6.2 | 17 ± 4.8 | 17 ± 4.0 |
| VEGF (ng mL−1) | 248 ± 93 | 256 ± 104 | 327 ± 120 | 129 ± 64 | 203 ± 97 | 134 ± 80 |
SRAUC, area under the shear rate curve to maximum dilatation; IGF‐I, Insulin like growth factor‐I; VEGF, vascular endothelial growth factor.
*P <0.05 versus LEX at same time‐point.
P <0.01 versus LEX and same time‐point.
P <0.05 versus Phase A in the same group.
P <0.01 versus Phase A in the same group.